Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL
Clinical trial NCT01562977 · COMPLETED
Trial details
- NCT number
- NCT01562977
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2015-04-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.